Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
copine 5 | 0.839 | 0.308 | 3.8E-04 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2013 | 2019 | ||||||||
|
C8orf37 antisense RNA 1 | 0.821 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2019 | |||||||||
|
coiled-coil domain containing 141 | 0.666 | 0.538 | 1.6E-33 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2013 | 2018 | ||||||||
|
myosin heavy chain 6 | 0.581 | 0.615 | 1.6E-32 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2010 | 2013 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 0.641 | 0.500 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
carbonic anhydrase 5A | 0.686 | 0.500 | 7.9E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
tissue factor pathway inhibitor | 0.486 | 0.808 | 0.25 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
fibronectin type III domain containing 3B | 0.674 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
regulatory factor X4 | 0.821 | 0.231 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
nucleotide binding protein like | 0.670 | 0.423 | 1.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
chromosome 1 open reading frame 21 | 0.890 | 0.154 | 0.89 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
KIAA1755 | 0.931 | 0.077 | 2.9E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
uromodulin like 1 | 0.931 | 0.038 | 4.3E-36 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
cytohesin 3 | 0.931 | 0.115 | 0.72 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
fatty acid desaturase 2 | 0.575 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
cadherin EGF LAG seven-pass G-type receptor 1 | 0.700 | 0.500 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2019 | 2019 | ||||||||
|
regulator of G protein signaling 6 | 0.564 | 0.769 | 0.44 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
MIR29B2 and MIR29C host gene | 0.839 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | |||||||||
|
ankyrin repeat and sterile alpha motif domain containing 1B | 0.686 | 0.423 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
membrane associated ring-CH-type finger 1 | 0.540 | 0.808 | 8.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 22 | 2018 | 2018 | ||||||||
|
long intergenic non-protein coding RNA 1782 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
DNA polymerase iota | 0.691 | 0.423 | 3.2E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2018 | 2018 | ||||||||
|
egl-9 family hypoxia inducible factor 3 | 0.575 | 0.654 | 9.5E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
cholinergic receptor muscarinic 2 | 0.585 | 0.615 | 0.18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
copine 8 | 0.890 | 0.115 | 8.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 |